ALSO NOTED: HGS pockets milestone money; CollaGenex files NDA; Large Scale Biology wins orphan drug status; and much more...

> Human Genome Sciences of Rockville, Maryland, has picked up $7 million in milestones from its partner, GlaxoSmithKline, which is advancing a late-stage diabetes therapy. Release

> CollaGenex has filed an NDA for Oracea, a treatment for rosacea. Story

> Large Scale Biology has won orphan drug status for its recombinant human Lysosomal Acid Lipase. Release

> Auxilium Pharmaceuticals of Malvern, Pennsylvania, has produced top-line findings from the Phase II trial for its androgen replacement product candidate. Release

And Finally… Researchers say obesity can be just as dangerous to your wealth as it is to your health. Story

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.